| J0301317 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2003-09-12 | | | Certificate Completed-Pending Issued | 2004-01-16 | view |
| JYHB2300381 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2023-07-08 | | Sanofi Winthrop Industrie | | | view |
| JYHB2400385 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2024-07-24 | | Sanofi Winthrop Industrie | | | view |
| JYHZ2200220 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | License Renew | 2022-08-17 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYHB2101411 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2021-09-15 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
| JYHB0500080 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2005-03-28 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Completed-Pending Issued | 2006-04-04 | view |
| JYHB2300639 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2023-11-08 | | Sanofi Winthrop Industrie | | | view |
| JYHB1200615 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2012-06-07 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Issued | 2013-04-16 | view |
| JYHB1000214 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2010-03-31 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Issued | 2011-04-08 | view |
| CYHS2501678 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs(4) | Generic Drug | 2025-05-09 | | Hunan Weite Pharmaceutical Co Ltd | | | view |
| CYHB2200294 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs(4) | Supplementary Application | 2022-02-10 | | Hunan Jiudian Pharmaceutical Co Ltd;Shandong Xinhua Pharmaceutical Company Limited | | | view |
| JYHB2300380 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2023-07-08 | | Sanofi Winthrop Industrie | | | view |
| JYHB1200318 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2012-04-12 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Issued | 2012-08-13 | view |
| JYHB2400384 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2024-07-24 | | Sanofi Winthrop Industrie | | | view |
| JYHZ2200221 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | License Renew | 2022-08-17 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| CYHB2201690 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs(4) | Supplementary Application | 2022-09-20 | | Zhuhai Rundu Pharmaceutical Co Ltd | | | view |
| JYHB0500079 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2005-03-28 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Completed-Pending Issued | 2006-04-04 | view |
| JYHB2300637 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2023-11-08 | | Sanofi Winthrop Industrie | | | view |
| JYHB1200614 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2012-06-07 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Issued | 2013-04-16 | view |
| CYHS2501627 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs(4) | Generic Drug | 2025-05-01 | | Guangzhou Baiyunshan Tianxin Pharmaceutical Co Ltd | | | view |
